The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials
Top Cited Papers
Open Access
- 12 September 2013
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 18 (37)
- https://doi.org/10.2807/1560-7917.es2013.18.37.20585
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matchesKeywords
This publication has 28 references indexed in Scilit:
- A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 SeasonClinical Infectious Diseases, 2012
- Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza VaccineClinical Infectious Diseases, 2012
- Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from CanadaPLoS Medicine, 2010
- Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young childrenVaccine, 2010
- Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and olderVaccine, 2009
- Estimation of Influenza Vaccine Effectiveness from Routine Surveillance DataPLOS ONE, 2009
- Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007The Journal of Infectious Diseases, 2009
- Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 SeasonThe Journal of Infectious Diseases, 2009
- Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart diseaseThe Journal of Pediatrics, 2003
- Pneumococcal Disease after Pneumococcal VaccinationNew England Journal of Medicine, 1980